Healthcare

Welcome to the home of healthcare on Law-Now.



On this page you can accessall the very latest articles and publications on issues affecting the healthcare sector.



To stay in touch with the latest developments, please bookmark this page on your mobile or register to receive eAlerts.

Recent Articles

  •  
    06.02.2023
    United Kingdom

    Cli­mate-re­lated dis­clos­ures – is your busi­ness aligned with the TCFD re­com­mend­a­tions?

    The Task Force on Climate-related Financial Disclosures recommendations aim to help organisations disclose clear, comparable, and consistent climate-related financial information. They are supported by organisations worldwide and have been implemented in the UK. The recommendations derive from the growing need for comparable climate-related disclosures and increasing regulation in this area. This article, part of our Healthy Horizons guide to doing business responsibly in Life Sciences & Healthcare, outlines how the recommendations are particularly important to Life Sciences & Healthcare...
    Read more
  •  
    06.02.2023
    United Kingdom

    Pre­view of UK Su­preme Court ap­peal: in­vent­or­ship and en­ti­tle­ment to AI in­ven­tions - DABUS

    A judgment by the UK Court of Appeal finding that inventions created by an AI machine are not patentable has been appealed to the UK Supreme Court and is due to be heard on 02 March 2023.Summary of the AppealThe applicant previously appealed a decision of the UK Intellectual Property Office (the ‘UK IPO’) that deemed two UK patent applications should be withdrawn as they named an AI machine, DABUS, as the inventor, a decision which was upheld by the High Court.The High Court decision was subsequently appealed to the Court of Appeal, with the central argument being that DABUS should...
    Read more
  •  
    03.02.2023
    International

    On your radar | Is­sue 20 | Key em­ploy­ment is­sues to be aware of in­ter­na­tion­ally

    Welcome to the first edition of On your radar for 2023, which highlights expected employment law developments over the year ahead.Changes range from big picture concepts around future ways of working, to the finer details of leave entitlements and statutory protections. Both Belgium and Portugal discuss moves towards a 4-day working week, showing a consistent trend, while demonstrating different domestic approaches to achieving that – interesting to see whether other countries will follow either.Another theme we continue to see coming through is ESG, and there are interesting...
    Read more
  •  
    24.01.2023
    Switzerland

    Pri­cing of Medi­cines in Switzer­land | Three-yearly price re­view: What are the most im­port­ant changes for 2023?

    DE
    The Federal Office of Public Health (FOPH) reviews the price of every medicinal product that is reimbursed under the statutory health insurance in Switzerland once every three years. These products are included in the list of pharmaceutical specialities (SL). However, the modalities of the review are often controversial and recent case-law requires periodic adjustments. This is no different for the 2023 review. While no fundamental changes are to be expected with regard to the review of the prices of medicinal products that are reimbursed by the mandatory healthcare insurance in Switzerland, there...
    Read more
  •  
    19.01.2023
    United Kingdom

    Gov­ern­ing for good

    Environmental, social and governance (“ESG”) considerations are increasingly important for business success. A sharpened focus is being placed on ESG matters by stakeholders, including potential corporate buyers, investors and partners, as they themselves continue to face greater pressures to uphold a higher standard across the industries and geographic regions in which they operate. For companies in the life sciences and healthcare (“LSHC”) sector, there is an inherent focus on social factors, and environmental issues (especially climate change) are now firmly in the mainstream....
    Read more
  •  
    18.01.2023
    Switzerland

    In Vitro Dia­gnost­ic Med­ic­al Devices: Tasks and Li­ab­il­it­ies of the Swiss Au­thor­ised Rep­res­ent­at­ive

    DE
    Foreign manufacturers of in vitro diagnostic devices medical devices must designate an authorised representative (CH-REP) to place their products on the Swiss market. To act on the manufacturer's behalf, the representative must perform various tasks and duties, including acting as the contact person for Swiss authorities and being jointly and severally liable with the manufacturer for damages caused by defective products. The following article is an overview of the tasks, duties and liabilities of the Swiss authorised representative of in vitro diagnostic medical devices. A Swiss authorised representative...
    Read more